Compare PRPL & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPL | SRTS |
|---|---|---|
| Founded | 2010 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.9M | 75.9M |
| IPO Year | 2015 | 2016 |
| Metric | PRPL | SRTS |
|---|---|---|
| Price | $0.70 | $3.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $1.00 | ★ $6.67 |
| AVG Volume (30 Days) | ★ 212.8K | 103.0K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.22 | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $487,877,000.00 | $27,482,000.00 |
| Revenue This Year | N/A | $3.81 |
| Revenue Next Year | $12.69 | $38.85 |
| P/E Ratio | $1.60 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.56 | $3.03 |
| 52 Week High | $1.26 | $5.92 |
| Indicator | PRPL | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 52.54 | 37.99 |
| Support Level | $0.65 | $3.63 |
| Resistance Level | $0.74 | $4.86 |
| Average True Range (ATR) | 0.04 | 0.28 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 80.04 | 12.17 |
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.